Pre Seed · Biotech · Niel, Belgium · Founded 2025 · 1–10 employees
Sightera Biosciences is a Belgian techbio company and academic spin-off from the University of Antwerp and Antwerp University Hospital. The company leverages generative artificial intelligence combined with proprietary, patient-derived biological data to design novel small-molecule therapies. By training its machine learning models on biological samples from patients with advanced, therapy-resistant, or end-stage diseases, the platform accelerates drug discovery in oncology and fibrosis applications. In July 2026, the startup secured a €3 million pre-seed funding round led by Entourage, Anacura, and QBIC.
No open roles listed right now.